• Zuclomiphene Safely Eases Hot Flashes Linked to ADT Use, Phase 2 Trial Reports
  • Rubraca Granted FDA Priority Review for Advanced Prostate Cancer with BRCA Mutations
  • Advaxis Seeks FDA Approval to Begin Phase 1 Trial of its ADXS-504 Immunotherapy for Prostate Cancer
  • Veyonda Plus Low-dose Radiotherapy May Halt Disease Progression in Late-Stage PC, Study Suggests
  • US Congress Increases Funding for Prostate Cancer Research for FY 2020
  • EMA Committee Favors Extending Use of Erleada for Metastatic Castration-sensitive Prostate Cancer
  • PyL Imaging Agent Accurately Detects Recurrent Prostate Cancer Lesions, Trial Shows
  • Lynparza Particularly Effective in Prostate Cancer Patients Carrying BRCA Mutations, Phase 2 Study Shows
  • FDA Expands Xtandi Approval to Include Metastatic Castration-sensitive Prostate Cancers
  • Prostate Cancer Campaigns Boost Enrollment in Study to Validate ClarityDX Diagnostic Test in Canada
  • Blank Family Foundation Donates $1M to Mount Sinai for Prostate Cancer Research
  • Lower Prostate Cancer Risk in Diabetics Likely Due to Fewer Biopsies, Not Medications, Study Says